Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Intensity modulated proton therapy for postmastectomy radiation of bilateral implant reconstructed breasts: a treatment planning study.

Jimenez RB, Goma C, Nyamwanda J, Kooy HM, Halabi T, Napolitano BN, McBride SM, Taghian AG, Lu HM, MacDonald SM.

Radiother Oncol. 2013 May;107(2):213-7. doi: 10.1016/j.radonc.2013.03.028.

PMID:
23647751
2.
3.

Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.

Seco J, Gu G, Marcelos T, Kooy H, Willers H.

Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):188-94. doi: 10.1016/j.ijrobp.2013.04.048.

PMID:
23920395
4.

Proton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment delivery.

MacDonald SM, Jimenez R, Paetzold P, Adams J, Beatty J, DeLaney TF, Kooy H, Taghian AG, Lu HM.

Radiat Oncol. 2013 Mar 24;8:71. doi: 10.1186/1748-717X-8-71.

5.

Minimising contralateral breast dose in post-mastectomy intensity-modulated radiotherapy by incorporating conformal electron irradiation.

van der Laan HP, Korevaar EW, Dolsma WV, Maduro JH, Langendijk JA.

Radiother Oncol. 2010 Feb;94(2):235-40. doi: 10.1016/j.radonc.2009.12.015.

PMID:
20080312
6.

Chest wall radiotherapy with volumetric modulated arcs and the potential role of flattening filter free photon beams.

Subramaniam S, Thirumalaiswamy S, Srinivas C, Gandhi GA, Kathirvel M, Kumar KK, Mallik S, Babaiah M, Pawar Y, Clivio A, Fogliata A, Mancosu P, Nicolini G, Vanetti E, Cozzi L.

Strahlenther Onkol. 2012 Jun;188(6):484-90. doi: 10.1007/s00066-012-0075-6.

PMID:
22402870
7.

Evaluation of bolus electron conformal therapy compared with conventional techniques for the treatment of left chest wall postmastectomy in patients with breast cancer.

Opp D, Forster K, Li W, Zhang G, Harris EE.

Med Dosim. 2013 Winter;38(4):448-53. doi: 10.1016/j.meddos.2013.08.002.

PMID:
24200221
8.

The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.

van der Laan HP, van de Water TA, van Herpt HE, Christianen ME, Bijl HP, Korevaar EW, Rasch CR, van 't Veld AA, van der Schaaf A, Schilstra C, Langendijk JA; Rococo cooperative group..

Acta Oncol. 2013 Apr;52(3):561-9. doi: 10.3109/0284186X.2012.692885.

PMID:
22708528
9.

A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.

Weber DC, Trofimov AV, Delaney TF, Bortfeld T.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1596-606.

PMID:
15050341
10.

Can proton therapy improve the therapeutic ratio in breast cancer patients at risk for nodal disease?

Xu N, Ho MW, Li Z, Morris CG, Mendenhall NP.

Am J Clin Oncol. 2014 Dec;37(6):568-74. doi: 10.1097/COC.0b013e318280d614.

PMID:
23466577
11.

Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.

Boehling NS, Grosshans DR, Bluett JB, Palmer MT, Song X, Amos RA, Sahoo N, Meyer JJ, Mahajan A, Woo SY.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):643-52. doi: 10.1016/j.ijrobp.2010.11.027.

PMID:
21277111
12.

Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy.

Krueger EA, Fraass BA, McShan DL, Marsh R, Pierce LJ.

Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1023-37.

PMID:
12829138
13.

No difference in dose distribution in organs at risk in postmastectomy radiotherapy with or without breast implant reconstruction.

Liljegren A, Unukovych D, Gagliardi G, Bjöhle J, Wickman M, Johansson H, Sandelin K.

Radiat Oncol. 2014 Jan 9;9:14. doi: 10.1186/1748-717X-9-14.

14.

Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients.

Mast ME, Vredeveld EJ, Credoe HM, van Egmond J, Heijenbrok MW, Hug EB, Kalk P, van Kempen-Harteveld LM, Korevaar EW, van der Laan HP, Langendijk JA, Rozema HJ, Petoukhova AL, Schippers JM, Struikmans H, Maduro JH.

Breast Cancer Res Treat. 2014 Nov;148(1):33-9. doi: 10.1007/s10549-014-3149-6.

15.

Postmastectomy intensity modulated radiation therapy following immediate expander-implant reconstruction.

Koutcher L, Ballangrud A, Cordeiro PG, McCormick B, Hunt M, Van Zee KJ, Hudis C, Beal K.

Radiother Oncol. 2010 Mar;94(3):319-23. doi: 10.1016/j.radonc.2009.12.003.

PMID:
20096946
16.

Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits?

Wang X, Zhang X, Li X, Amos RA, Shaitelman SF, Hoffman K, Howell R, Salehpour M, Zhang SX, Sun TL, Smith B, Tereffe W, Perkins GH, Buchholz TA, Strom EA, Woodward WA.

Br J Radiol. 2013 Sep;86(1029):20130176. doi: 10.1259/bjr.20130176.

17.

Respiratory gating for proton beam scanning versus photon 3D-CRT for breast cancer radiotherapy.

Flejmer AM, Edvardsson A, Dohlmar F, Josefsson D, Nilsson M, Witt Nyström P, Dasu A.

Acta Oncol. 2016 May;55(5):577-83. doi: 10.3109/0284186X.2015.1120883.

PMID:
27027913
18.

Quantifying the impact of immediate reconstruction in postmastectomy radiation: a large, dose-volume histogram-based analysis.

Ohri N, Cordeiro PG, Keam J, Ballangrud A, Shi W, Zhang Z, Nerbun CT, Woch KM, Stein NF, Zhou Y, McCormick B, Powell SN, Ho AY.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e153-9. doi: 10.1016/j.ijrobp.2012.03.026.

PMID:
22560544
19.

Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.

Baumert BG, Norton IA, Lomax AJ, Davis JB.

Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1314-24.

PMID:
15519805
20.

Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: a treament planning comparison.

Fellin F, Azzeroni R, Maggio A, Lorentini S, Cozzarini C, Di Muzio N, Fiorino C, Calandrino R, Schwarz M.

Radiother Oncol. 2013 May;107(2):207-12. doi: 10.1016/j.radonc.2013.02.016.

PMID:
23541644

Supplemental Content

Support Center